Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate [Phase 2]

View source ↗

Summary

Update on a Phase 2 trial evaluating ASP5094 in rheumatoid arthritis patients on methotrexate; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASP5094
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Rheumatoid Arthritis (RA) | Phase 2 | Status: COMPLETED